836. Significant Elevations in CD4(+) Count, Post-treatment of Chronic Hepatitis C (HCV) with Direct Acting Antivirals (DAAs), in Human Immune Deficiency, HIV/HCV Co-infected Patients with Prolonged CD4+ lymphocytopenia, despite undetectable HIV RNA

BACKGROUND: Introduction of DAAs has revolutionized HCV therapy. Treatment of HIV/HCV co-infected patients is challenging and HCV treatment data on this group of patients are limited. Aim: To review pre-and post-DAA treatment parameters, identify measures to improve recruitment and improve quality o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuhn, Ryan, Green, Carolyn, Natesan, Suganthini Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644088/
http://dx.doi.org/10.1093/ofid/ofab466.1032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644088/
http://dx.doi.org/10.1093/ofid/ofab466.1032

Ejemplares similares